Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C13H18N2O4S2 |
Molecular Weight | 330.423 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CSCC=C)C(O)=O
InChI
InChIKey=QULKGELYPOJSLP-WCABBAIRSA-N
InChI=1S/C13H18N2O4S2/c1-4-5-20-6-7(16)14-8-10(17)15-9(12(18)19)13(2,3)21-11(8)15/h4,8-9,11H,1,5-6H2,2-3H3,(H,14,16)(H,18,19)/t8-,9+,11-/m1/s1
Molecular Formula | C13H18N2O4S2 |
Molecular Weight | 330.423 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
1000000 unit 1 times / day multiple, intramuscular Highest studied dose Dose: 1000000 unit, 1 times / day Route: intramuscular Route: multiple Dose: 1000000 unit, 1 times / day Sources: |
unhealthy, 23 years n = 1 Health Status: unhealthy Condition: rheumatoid spondylitis Age Group: 23 years Sex: M Population Size: 1 Sources: |
Other AEs: Nausea, Increased salivation... |
600000 unit single, intramuscular Dose: 600000 unit Route: intramuscular Route: single Dose: 600000 unit Sources: |
unhealthy, 23 years n = 1 Health Status: unhealthy Condition: rheumatoid spondylitis Age Group: 23 years Sex: M Population Size: 1 Sources: |
Disc. AE: Anaphylactic shock... AEs leading to discontinuation/dose reduction: Anaphylactic shock (severe) Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Increased salivation | 1000000 unit 1 times / day multiple, intramuscular Highest studied dose Dose: 1000000 unit, 1 times / day Route: intramuscular Route: multiple Dose: 1000000 unit, 1 times / day Sources: |
unhealthy, 23 years n = 1 Health Status: unhealthy Condition: rheumatoid spondylitis Age Group: 23 years Sex: M Population Size: 1 Sources: |
|
Nausea | mild | 1000000 unit 1 times / day multiple, intramuscular Highest studied dose Dose: 1000000 unit, 1 times / day Route: intramuscular Route: multiple Dose: 1000000 unit, 1 times / day Sources: |
unhealthy, 23 years n = 1 Health Status: unhealthy Condition: rheumatoid spondylitis Age Group: 23 years Sex: M Population Size: 1 Sources: |
Anaphylactic shock | severe Disc. AE |
600000 unit single, intramuscular Dose: 600000 unit Route: intramuscular Route: single Dose: 600000 unit Sources: |
unhealthy, 23 years n = 1 Health Status: unhealthy Condition: rheumatoid spondylitis Age Group: 23 years Sex: M Population Size: 1 Sources: |
PubMed
Title | Date | PubMed |
---|---|---|
Use of penicillin O in patients hypersensitive to pencilling G. | 1950 Jul 1 |
|
Clinical and pharmacologic studies with allylmercaptomethyl penicillin (penicillin O). | 1951 Aug |
|
Studies on the mechanism of the formation of the penicillin antigen. I. Delayed allergic cross-reactions among penicillin G and its degradation products. | 1960 Dec 1 |
|
Some immunochemical properties of penicillenic acid. An antigenic determinant derived from penicillin. | 1960 Dec 1 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:45:27 GMT 2023
by
admin
on
Fri Dec 15 15:45:27 GMT 2023
|
Record UNII |
6246WH0S1O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1500
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1575
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | |||
|
m8478
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | Merck Index | ||
|
C80247
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | |||
|
51207
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | |||
|
DTXSID50236034
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105909
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | |||
|
71365
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | |||
|
87-09-2
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | |||
|
6246WH0S1O
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | |||
|
100000087440
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | |||
|
3422
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | |||
|
Almecillin
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY | |||
|
SUB05345MIG
Created by
admin on Fri Dec 15 15:45:27 GMT 2023 , Edited by admin on Fri Dec 15 15:45:27 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |